CanSemi Technology's Shenzhen IPO Oversubscribed 2,360 Times Ahead of ChiNext Debut
CanSemi Technology, a chip foundry based in China, has experienced an incredible 2,360 times oversubscription for its initial public offering in Shenzhen, positioning it as one of the most coveted tech listings in mainland China this year. Investors are enthusiastic about the firm’s advancements in silicon photonics and its contributions to the local artificial intelligence infrastructure. Upon the commencement of trading, CanSemi is anticipated to achieve a significant milestone as the first dedicated wafer fabrication firm to be listed on the ChiNext board, which is Shenzhen's technology-focused market segment. Excitement is mounting as the company approaches its debut in Shenzhen.
Key facts
- CanSemi Technology's Shenzhen IPO was oversubscribed 2,360 times
- The listing is among mainland China's most sought-after tech IPOs this year
- Investors are betting on CanSemi's silicon photonics push
- CanSemi plays a role in domestic artificial intelligence infrastructure
- CanSemi is expected to be the first pure-play wafer fabrication company on Shenzhen's ChiNext board
- The debut is anticipated to set a milestone for the Shenzhen exchange
- Trading has not yet begun at the time of the report
- The company is a Chinese chip foundry
Entities
Institutions
- CanSemi Technology
- Shenzhen Stock Exchange
- ChiNext
- South China Morning Post
Locations
- Shenzhen
- China